Birsen Yucel
Overview
Explore the profile of Birsen Yucel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yilmaz M, Erdis E, Ucar M, Yucel B
Breast Care (Basel)
. 2025 Mar;
20(1):27-39.
PMID: 40046313
Introduction: The present study evaluated the prognostic significance of panimmune-inflammation value (PIV) and PILE (a composite score of PIV, lactate dehydrogenase [LDH], and Eastern Cooperative Oncology Group Performance Status [ECOG...
2.
Ucar M, Yilmaz M, Erdis E, Yucel B
Medicina (Kaunas)
. 2025 Feb;
61(2).
PMID: 40005427
Mixed ductolobular carcinomas (mDLCs) are tumors that contain both ductal and lobular components. The clinicopathological characteristics and impacts on survival of the two components, which have distinct biological behaviors, are...
3.
Yucel B, Aslan D, Yaprak G, Guney Y, Erpolat P, Cetinayak O, et al.
Turk Neurosurg
. 2024 Aug;
34(5):809-818.
PMID: 39087286
Aim: To evaluate survival and prognostic factors associated with survival among patients who underwent reirradiation for recurrent/ progressive primary brain tumors. Material And Methods: A multicenter, retrospective study (7 centers,...
4.
Sert F, Gorken I, Ozkok S, Oksuz D, Yucel B, Kaytan Saglam E, et al.
Asian J Surg
. 2024 Mar;
47(7):3056-3062.
PMID: 38443256
Objectives: We aimed to develop a basic, easily applicable nomogram to improve the survival prediction of the patients with stage II/III gastric cancer (GC) and to select the best candidate...
5.
Yilmaz M, Erdis E, Ucar M, Demir N, Alandag C, Yucel B
Jpn J Clin Oncol
. 2024 Feb;
54(5):521-529.
PMID: 38336481
Background: In the current study, the effect of hormone receptor (HR) status on clinical and survival in early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer was investigated. Methods:...
6.
Yilmaz M, Erdis E, Ucar M, Yucel B
Support Care Cancer
. 2023 Sep;
31(10):600.
PMID: 37770678
Purpose: The aim of this study was to evaluate quality of life (QoL) in patients with gastric adenocarcinoma receiving adjuvant chemoradiotherapy (CRT). Methods: The European Organization for Cancer Research and...
7.
Yucel B, Erdis E, Bahar S, Akkas Atasever E, Celasun M, Altuntas E
Turk Arch Otorhinolaryngol
. 2023 Jul;
60(4):212-219.
PMID: 37456600
Objective: This study aimed to investigate the factors affecting permanent sensorineural hearing loss (SNHL) and causing changes in bone conduction (BC) thresholds over time in patients after receiving radiotherapy (RT)...
8.
Atasever Akkas E, Erdis E, Yucel B
Eur Arch Otorhinolaryngol
. 2023 Jun;
280(8):3831-3833.
PMID: 37289280
No abstract available.
9.
Atasever Akkas E, Erdis E, Yucel B
Eur Arch Otorhinolaryngol
. 2023 Apr;
280(8):3821-3830.
PMID: 37029321
Purpose: This study sought to investigate the prognostic value of the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and prognostic nutritional index (PNI) in patients with head and...
10.
Erturk S, Salk I, Yucel B, Ulas Babacan O, Hasbek Z
Arch Esp Urol
. 2022 Sep;
75(6):552-558.
PMID: 36138505
Objectives: ALP and LDH are serum markers of prognostic importance in prostate cancer patients. PET/CT imaging with Ga-68 PSMA has played an important role in prostate cancer imaging in recent...